arrow_back Back Filing freshness 20-F Q4 FY2025 SEC EDGAR

YD Bio Ltd

YDES
$7.28 ▲ +0.23 (+3.26%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
4 Visible periods
5 Metrics
Peer-ranked Benchmarks
Price Chart
90
Health
Excellent
Bullish
auto_awesome

Analytical Summary

YD Bio Ltd shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC —
FCF / Share —
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Returns ↑
100
Cash Quality
64

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 4 years · 4 quarters